Cargando…

β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature

β-Blockers (BBs) are an essential class of cardiovascular medications for reducing morbidity and mortality in patients with heart failure (HF). However, a large body of data indicates that BBs should not be used as first-line therapy for hypertension (HTN). Additionally, new data have questioned the...

Descripción completa

Detalles Bibliográficos
Autores principales:	DiNicolantonio, James J, Fares, Hassan, Niazi, Asfandyar K, Chatterjee, Saurav, D'Ascenzo, Fabrizio, Cerrato, Enrico, Biondi-Zoccai, Giuseppe, Lavie, Carl J, Bell, David S, O'Keefe, James H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2015
Materias:	Cardiac Risk Factors and Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371808/ https://www.ncbi.nlm.nih.gov/pubmed/25821584 http://dx.doi.org/10.1136/openhrt-2014-000230

Ejemplares similares

Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes
por: Fares, Hassan, et al.
Publicado: (2016)

Angiotensin receptor blockers for prevention of cardiovascular disease: where does the evidence stand?
por: Fuchs, Flávio Danni, et al.
Publicado: (2015)

Capsaicin may have important potential for promoting vascular and metabolic health
por: McCarty, Mark F, et al.
Publicado: (2015)

Nutritional strategies for skeletal and cardiovascular health: hard bones, soft arteries, rather than vice versa
por: O'Keefe, James H, et al.
Publicado: (2016)

The wrong white crystals: not salt but sugar as aetiological in hypertension and cardiometabolic disease
por: DiNicolantonio, James J, et al.
Publicado: (2014)

Lauric acid-rich medium-chain triglycerides can substitute for other oils in cooking applications and may have limited pathogenicity
por: McCarty, Mark F, et al.
Publicado: (2016)

Is concomitant aspirin helping novel oral anticoagulants? Focus on apixaban
por: DiNicolantonio, James J, et al.
Publicado: (2014)

Comparative effectiveness of ACE inhibitors and angiotensin receptor blockers in patients with prior myocardial infarction
por: Ko, Dennis, et al.
Publicado: (2019)

Addition of cystatin C predicts cardiovascular death better than creatinine in intensive care
por: Helmersson-Karlqvist, Johanna, et al.
Publicado: (2022)

Cardiovascular risk after hospitalisation for unexplained syncope and orthostatic hypotension
por: Yasa, Ekrem, et al.
Publicado: (2018)

Interhospital and interindividual variability in secondary prevention: a comparison of outpatients with a history of chronic coronary syndrome versus outpatients with a history of acute coronary syndrome (the iASPIRE Study)
por: Curneen, James MG, et al.
Publicado: (2021)

Do age, period or cohort effects explain circulatory disease mortality trends, Scotland 1974–2015?
por: Parkinson, Jane, et al.
Publicado: (2020)

Meta-analysis of secure randomised controlled trials of β-blockade to prevent perioperative death in non-cardiac surgery
por: Bouri, Sonia, et al.
Publicado: (2014)

Identification of an increased lifetime risk of major adverse cardiovascular events in UK Biobank participants with scoliosis
por: Quintero Santofimio, Valentina, et al.
Publicado: (2023)

Sex-specific trajectories of molecular cardiometabolic traits from childhood to young adulthood
por: O'Keeffe, Linda M, et al.
Publicado: (2023)

Time-based measures of treatment effect: reassessment of ticagrelor and clopidogrel from the PLATO trial
por: Bellavia, Andrea, et al.
Publicado: (2017)

Predictors of cardiovascular health in teenagers (aged 13–14 years): a cross-sectional study linked with routine data
por: James, Michaela, et al.
Publicado: (2019)

Association of occupational exposures with cardiovascular disease among US Hispanics/Latinos
por: Bulka, Catherine M, et al.
Publicado: (2019)

Association of hypertension with mortality in patients hospitalised with COVID-19
por: Bhatia, Kunwardeep S, et al.
Publicado: (2021)

High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS/MS) urine analysis
por: Tomaszewski, Maciej, et al.
Publicado: (2014)

Prescription of secondary prevention medications, lifestyle advice, and referral to rehabilitation among acute coronary syndrome inpatients: results from a large prospective audit in Australia and New Zealand
por: Redfern, Julie, et al.
Publicado: (2014)

Short-term effects of air pollution on a range of cardiovascular events in England and Wales: case-crossover analysis of the MINAP database, hospital admissions and mortality
por: Milojevic, Ai, et al.
Publicado: (2014)

On site assessment of cardiac function and neural regulation in amateur half marathon runners
por: Dalla Vecchia, Laura, et al.
Publicado: (2014)

B-type natriuretic peptide-guided therapy for perioperative medicine?
por: Shang, Charles
Publicado: (2014)

Subclinical atherosclerosis and silent myocardial ischaemia in patients with type 2 diabetes: a protocol of a clinico-observational study
por: Prasad, D S, et al.
Publicado: (2014)

Stress resilience and physical fitness in adolescence and risk of coronary heart disease in middle age
por: Bergh, Cecilia, et al.
Publicado: (2015)

Cardiovascular risk profile and frailty in a population-based study of older British men
por: Ramsay, S E, et al.
Publicado: (2015)

Prerace aspirin to protect susceptible runners from cardiac arrest during marathons: is opportunity knocking?
por: Siegel, Arthur J
Publicado: (2015)

Alcohol consumption and risk of incident heart failure in older men: a prospective cohort study
por: Wannamethee, S Goya, et al.
Publicado: (2015)

Natriuretic peptides for the detection of paroxysmal atrial fibrillation
por: Seegers, Joachim, et al.
Publicado: (2015)

Lean body mass index prognostic value for cardiovascular events in patients with coronary artery disease
por: Hioki, Hirofumi, et al.
Publicado: (2015)

Association of ambulatory heart rate and atherosclerosis risk factors with blood pressure in young non-hypertensive adults
por: Cheng, Cynthia, et al.
Publicado: (2016)

Cardiac function associated with previous, current and repeated depression and anxiety symptoms in a healthy population: the HUNT study
por: Gustad, L T, et al.
Publicado: (2016)

Estimated 10-year cardiovascular mortality seriously underestimates overall cardiovascular risk
por: Jørstad, Harald T, et al.
Publicado: (2016)

Does the timing of cardiac rehabilitation impact fitness outcomes? An observational analysis
por: Fell, Jennifer, et al.
Publicado: (2016)

Observational study of the relationship between volume and outcomes using data from the National Audit of Cardiac Rehabilitation
por: Doherty, Patrick, et al.
Publicado: (2015)

Dynamic cycling in atrial size and flow during obstructive apnoea
por: Pressman, Gregg S, et al.
Publicado: (2016)

Cardiac rehabilitation using the Family-Centered Empowerment Model versus home-based cardiac rehabilitation in patients with myocardial infarction: a randomised controlled trial
por: Vahedian-Azimi, Amir, et al.
Publicado: (2016)

Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases
por: Pujades-Rodriguez, Mar, et al.
Publicado: (2016)

Distribution of lifespan gain from primary prevention intervention
por: Finegold, Judith A, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9llt1fr2qnv94mieu7odnj80en